Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Triptolide Cooperates with Cytarabine To Induce Apoptosis in Acute Myeloid Leukemia.

Arnaud Pigneux, MD, Maïalen Uhalde, PhD, François X. Mahon, MD,PhD, Francis Lacombe, PhD, Vincent Praloran, MD,PhD, Noel-Jean Milpied, MD, Francis Belloc, PhD

Blood (2006) 108 (11): 1902.

https://doi.org/10.1182/blood.V108.11.1902.1902

Published: 2006

Journal Articles

Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

Marjorie Boissinot, Eric Lippert, Francois Girodon, Irene Dobo, Marc Fouassier, Claude Masliah, Vincent Praloran, Sylvie Hermouet

Blood (2006) 108 (9): 3223–3224.

https://doi.org/10.1182/blood-2006-05-021527

Published: 2006

Journal Articles

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

Eric Lippert, Marjorie Boissinot, Robert Kralovics, François Girodon, Irène Dobo, Vincent Praloran, Nathalie Boiret-Dupré, Radek C. Skoda, Sylvie Hermouet

Blood (2006) 108 (6): 1865–1867.

https://doi.org/10.1182/blood-2006-01-013540

Published: 2006

Journal Articles

Proteasome Inhibition Sensitizes Leukemic Cells to Anthracyclin-Induced Apoptosis by Increasing the Expression of Bim and Bax Pro-Apoptotic Proteins.

Arnaud Pigneux, MD, François X. Mahon, MD, PhD, François Moreau-Gaudry, PhD, Marie L. Néré, Francis Lacombe, MD, PhD, Josy Reiffers, MD, Vincent Praloran, MD, Francis Belloc, PhD

Blood (2005) 106 (11): 2487.

https://doi.org/10.1182/blood.V106.11.2487.2487

Published: 2005

Journal Articles

Quantitative Analysis of Wild Type and V617F JAK-2 Expression in Neutrophils of Polycythemia Vera and Essential Thrombocythemia Patients at Diagnosis.

Eric Lippert, MD, Francois Girodon, MD, Robert Kralovics, PhD, Marjorie Boissinot, Irene Dobo, Vincent Praloran, MD, Nathalie Boiret, MD, Radek C. Skoda, MD, Sylvie Hermouet, MD

Blood (2005) 106 (11): 257.

https://doi.org/10.1182/blood.V106.11.257.257

Published: 2005

Journal Articles

Bim-EL, Is Sensitive to Proteasome Degradation and Contributes to Inducing Apoptosis after In Vitro Imatinib Mesylate Treatment of BCR-ABL Positive Cells.

Francis Belloc, PhD, Catherine Boyer, Francis Lacombe, MD, PhD, Vincent Praloran, MD, François-Xavier Mahon, MD, PhD

Blood (2004) 104 (11): 4676.

https://doi.org/10.1182/blood.V104.11.4676.4676

Published: 2004

Journal Articles

Expression of HMGA2 in PB Leukocytes and Purified CD34+ Cells from Normal Individuals and Patients with Myelofibrosis and Myeloid Metaplasia.

Joris R. Andrieux, MD, PhD, Chrystèle Bilhou-Nabera, MD, Jean Loup Demory, MD, Olivier Pierre-Louis, Brigitte Dupriez, MD, Nathalie Grardel, MD, Agnès Charpentier, MD, Vincent Praloran, MD, Francis Bauters, MD, Jean Luc Laï, PhD, Marie-Caroline Le Bousse-Kerdilès, PhD

Blood (2004) 104 (11): 2435.

https://doi.org/10.1182/blood.V104.11.2435.2435

Published: 2004

Journal Articles

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Chrystèle Bilhou-Nabera, MD, PhD, Joris R. Andrieux, MD, PhD, Olivier Pierre-Louis, Marie-Caroline Le Bousse-Kerdilès, PhD, Brigitte Dupriez, MD, Nathalie Grardel, MD, Agnès Charpentier, MD, Vincent Praloran, MD, Francis Bauters, MD, Jean Luc Laï, PhD, Jean Loup Demory, MD

Blood (2004) 104 (11): 2436.

https://doi.org/10.1182/blood.V104.11.2436.2436

Published: 2004

Journal Articles

Discriminative HMGA2 Isoform Expression in CD15+ Granulocytic Cells in Myeloid Metaplasia with Myelofibrosis (MMM).

Olivier Pierre-Louis, Joris Andrieux, MD, PhD, Christophe Desterke, Eric Lippert, MD, PhD, Vincent Praloran, MD, PhD, Jean-Loup Demory, MD, Marie-Caroline Le Bousse-Kerdiles, PhD, Chrystele Bilhou-Nabera, MD, PhD

Blood (2004) 104 (11): 2429.

https://doi.org/10.1182/blood.V104.11.2429.2429

Published: 2004

Journal Articles

Does cytogenetic mosaicism in CD34 + CD38 low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?

Chrystèle Bilhou-Nabéra, Christophe Brigaudeau, Denis Clay, Joris Andrieux, Jean-Luc Lai, Danielle Brouty-Boyé, Christine Vignon, Marie-Josée Gharbi, Marie-Caroline Le Bousse-Kerdilès, Vincent Praloran, the members of the French INSERM Network on Myeloid Metaplasia with Myelofibrosis

Blood (2003) 102 (4): 1551–1552.

https://doi.org/10.1182/blood-2003-03-0691

Published: 2003

Journal Articles

Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

Jean-François Viallard, Anne Solanilla, Bruno Gauthier, Cécile Contin, Julie Déchanet, Christophe Grosset, Jean-François Moreau, Vincent Praloran, Paquita Nurden, Jean-Luc Pellegrin, Alan T. Nurden, Jean Ripoche

Blood (2002) 99 (7): 2612–2614.

https://doi.org/10.1182/blood.V99.7.2612

Published: 2002

NARROW

Triptolide Cooperates with Cytarabine To Induce Apoptosis in Acute Myeloid Leukemia.

Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

Proteasome Inhibition Sensitizes Leukemic Cells to Anthracyclin-Induced Apoptosis by Increasing the Expression of Bim and Bax Pro-Apoptotic Proteins.

Quantitative Analysis of Wild Type and V617F JAK-2 Expression in Neutrophils of Polycythemia Vera and Essential Thrombocythemia Patients at Diagnosis.

Bim-EL, Is Sensitive to Proteasome Degradation and Contributes to Inducing Apoptosis after In Vitro Imatinib Mesylate Treatment of BCR-ABL Positive Cells.

Expression of HMGA2 in PB Leukocytes and Purified CD34+ Cells from Normal Individuals and Patients with Myelofibrosis and Myeloid Metaplasia.

HMGA2 Dysregulation in Myelofibrosis with Myeloïd Metaplasia (MMM) Versus Other Phi-Negative Chronic Myeloproliferative Disorders and Myelodysplasia.

Discriminative HMGA2 Isoform Expression in CD15+ Granulocytic Cells in Myeloid Metaplasia with Myelofibrosis (MMM).

Does cytogenetic mosaicism in CD34 + CD38 low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?

Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only